Cotransplantation of mesenchymal stem cells and endothelial progenitor cells for treating steroid‐induced osteonecrosis of the femoral head
Abstract Steroid‐induced osteonecrosis of the femoral head (ONFH) is characterized by decreased osteogenesis, angiogenesis, and increased adipogenesis. While bone tissue engineering has been widely investigated to treat ONFH, its therapeutic effects remain unsatisfactory. Therefore, further studies...
Main Authors: | Haixia Xu, Chengqiang Wang, Chun Liu, Ziyue Peng, Jianjun Li, Yanglei Jin, Yihan Wang, Jiasong Guo, Lixin Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-05-01
|
Series: | Stem Cells Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/sctm.20-0346 |
Similar Items
-
BADGE, a synthetic antagonist for PPARγ, prevents steroid-related osteonecrosis in a rabbit model
by: Na Yuan, et al.
Published: (2018-04-01) -
Cell-based Treatments of Femoral Head Osteonecrosis: A Literature Review
by: Ali Parsa, et al.
Published: (2018-06-01) -
Stem cell therapy for osteonecrosis of femoral head: Opportunities and challenges
by: Yingxing Xu, et al.
Published: (2020-12-01) -
The Protective Effect of Cordycepin On Alcohol-Induced Osteonecrosis of the Femoral Head
by: Yi-Xuan Chen, et al.
Published: (2017-08-01) -
PTEN inhibitor VO-OHpic attenuates GC-associated endothelial progenitor cell dysfunction and osteonecrosis of the femoral head via activating Nrf2 signaling and inhibiting mitochondrial apoptosis pathway
by: Xudong Yao, et al.
Published: (2020-03-01)